These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23461768)

  • 1. Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs).
    Arefi S; Mottaghi S; Sharifi AM
    Gynecol Endocrinol; 2013 May; 29(5):470-3. PubMed ID: 23461768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
    Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
    Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of plasma renin activity and angiotensin II levels in women with polycystic ovary syndrome].
    Li X; Shen H; Ge X
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):586-7. PubMed ID: 11372405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome.
    Karabulut A; Turgut S; Turgut G
    Gynecol Endocrinol; 2010 Jun; 26(6):393-8. PubMed ID: 20170341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
    Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS.
    Celik O; Yesilada E; Hascalik S; Celik N; Sahin I; Keskin L; Ozerol E
    Reprod Biomed Online; 2010 Apr; 20(4):492-8. PubMed ID: 20138007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls.
    Cho LW; Kilpatrick ES; Keevil BG; Jayagopal V; Coady AM; Rigby AS; Atkin SL
    Horm Metab Res; 2011 Feb; 43(2):141-5. PubMed ID: 21234853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone.
    Armanini D; Bordin L; Donà G; Sabbadin C; Bakdounes L; Ragazzi E; Giorgino FL; Fiore C
    Steroids; 2012 May; 77(6):655-8. PubMed ID: 22387621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
    Celik O; Sahin I; Celik N; Hascalik S; Keskin L; Ozcan H; Uckan A; Kosar F
    Hum Reprod; 2007 Nov; 22(11):2992-8. PubMed ID: 17855407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
    Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D
    Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.